Clinical Trials

“Cancer patients treated on clinical trials lived substantially longer than those not treated on trial.” -Journal of ClinicalOncology, 2018 using 12 million patient registry data from National Cancer Database


0 +

Active Studies

0 +

Active Studies
Cancer Types


Cancer Types

Why join a clinical trial?

Clinical trials help advance research and treatment options for cancer patients. If you have an advanced cancer, a rare cancer, or a cancer that has not responded to standard treatment options, exploring a clinical trial may be your best option.

New clinical trials added on Oct 30, 2023

  • Serum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast Cancer

    NCT Number : NCT06097546

  • Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm Lymphedema

    NCT Number : NCT06095323

  • Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

    NCT Number : NCT06091943

  • Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery

    NCT Number : NCT06094621

  • Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer

    NCT Number : NCT06097416

  • The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal Cancer

    NCT Number : NCT06092242

  • ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study

    NCT Number : NCT06095674

  • Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer

    NCT Number : NCT06094842

  • Enzalutamide and M9241 in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

    NCT Number : NCT06096870

  • The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

    NCT Number : NCT06096623

  • Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    NCT Number : NCT06096844

  • cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis

    NCT Number : NCT06098248

  • Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer

    NCT Number : NCT06097078

  • A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer

    NCT Number : NCT06095089

  • A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6

    NCT Number : NCT06091930

  • A Study of HY-0102 in Patients With Advanced Solid Tumors

    NCT Number : NCT06094777

  • INvestigating DIGital Outcomes in the Community

    NCT Number : NCT06095024

  • A Study to Assess Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

    NCT Number : NCT06095583

  • A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

    NCT Number : NCT06095505

  • IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

    NCT Number : NCT06092892

  • Randomized Controlled, Open Clinical Study on Efficacy and Safety of Acupuncture for Bladder Function Recovery After Radical Cervical Cancer Surgery

    NCT Number : NCT06095882

  • Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

    NCT Number : NCT06096038

  • Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications

    NCT Number : NCT06097156

  • Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein

    NCT Number : NCT06093503

  • Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

    NCT Number : NCT06098404

  • Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

    NCT Number : NCT06096974

  • Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency

    NCT Number : NCT06095141

  • Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS

    NCT Number : NCT06098118

  • Axillary Management After Neoadjuvant Chemotherapy

    NCT Number : NCT06096545

  • A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

    NCT Number : NCT06094296

  • UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

    NCT Number : NCT06092047

  • A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

    NCT Number : NCT06092268

  • An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors

    NCT Number : NCT06094556

  • Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer

    NCT Number : NCT06094868

  • Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum

    NCT Number : NCT06096493

  • Prognostic Markers for a Better Follow-up in Head and Neck Cancer.

    NCT Number : NCT06094985

  • Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

    NCT Number : NCT06096688

  • New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer

    NCT Number : NCT06097936

  • Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer

    NCT Number : NCT06093438

  • Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

    NCT Number : NCT06093425

  • NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer

    NCT Number : NCT06094140

  • An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases

    NCT Number : NCT06093698

  • 18F-FAPI-RGD PET/CT in Various Tumor Types

    NCT Number : NCT06094530

  • Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study

    NCT Number : NCT06093022

  • Intraoperative Radiotherapy in Treating Spinal Metastases

    NCT Number : NCT06093854

  • Phase 1 Study of AWT020 in Advanced Cancer

    NCT Number : NCT06092580

  • Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

    NCT Number : NCT06093061

  • Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer

    NCT Number : NCT06092450

  • Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

    NCT Number : NCT06094426

  • A Biomarker Study for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients

    NCT Number : NCT06098560

  • A Study of DCR-STAT3 in Adults With Solid Tumors

    NCT Number : NCT06098651

  • A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

    NCT Number : NCT06092606

  • RE-irradiation of Diffuse MIdline Glioma paTients

    NCT Number : NCT06093165

  • Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

    NCT Number : NCT06093971

  • Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer

    NCT Number : NCT02397434

  • Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC

    NCT Number : NCT06092086

  • Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

    NCT Number : NCT06093945

  • Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC

    NCT Number : NCT06095167

  • Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma

    NCT Number : NCT06092645

  • Improvement of Quality of Life by Cannabinoids in Oncologic Patients

    NCT Number : NCT06097533

  • Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

    NCT Number : NCT06097468

  • A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis

    NCT Number : NCT06096779

  • A Study of SVZ Irradiation With Postoperative Radiotherapy in Patients With GBM.

    NCT Number : NCT06092255

  • Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging

    NCT Number : NCT06094322

  • LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma

    NCT Number : NCT06098547

  • Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients

    NCT Number : NCT06094257

  • New-mode Clinical Target Volume Delineation of Nasopharyngeal Carcinoma

    NCT Number : NCT06095154

  • Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF

    NCT Number : NCT06097338

  • A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma

    NCT Number : NCT06097975

  • A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma

    NCT Number : NCT06092112

  • Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral Mucosa

    NCT Number : NCT06094829

  • Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome

    NCT Number : NCT06093048

  • Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy

    NCT Number : NCT06092944

  • A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants

    NCT Number : NCT06092931

  • MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

    NCT Number : NCT06097728

  • Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation

    NCT Number : NCT06093867

  • A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza

    NCT Number : NCT06094010

  • Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

    NCT Number : NCT06092125

  • VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

    NCT Number : NCT06092333

  • Watchful Waiting for Patients With Multifocal Ground-glass Opacities (ECTOP-1021)

    NCT Number : NCT06097910

  • Nourishing the Community Through Culinary Medicine- Acres Homes

    NCT Number : NCT06096506

  • Pulmonary MRI Using Ultra Short /Zero TE Sequences

    NCT Number : NCT06097741

  • Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

    NCT Number : NCT06095596

  • Analysis of Urinary, Vaginal and Intestinal Microbiota in Patients With Neurogenic Bladder

    NCT Number : NCT06093035

  • Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)

    NCT Number : NCT06094101

  • Culturally Tailored HPV Psychoeducational Multimedia Intervention

    NCT Number : NCT06098690

  • Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD

    NCT Number : NCT06093334

  • The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study

    NCT Number : NCT06096896

  • Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

    NCT Number : NCT06092957

  • Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

    NCT Number : NCT06097832

  • Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

    NCT Number : NCT06092879

  • Safety and Efficacy of NK510 to Treat NSCLC

    NCT Number : NCT06097962

  • Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment

    NCT Number : NCT06095934

  • Relmacabtagene Autoleucel as Second-Line Therapy in Adult Patients With Aggressive B-cell NHL

    NCT Number : NCT06093841

  • The Effect of Bilateral Rectus Sheath Block Versus Wound Infiltration in Gynecooncological Patients

    NCT Number : NCT06095908

  • Nexpowder to Prevent Delayed Bleeding After Endoscopic Resection

    NCT Number : NCT06096948

  • A Study to Learn How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Compared to Rituximab and Chemotherapy in Adult Participants With Previously Untreated Follicular Lymphoma

    NCT Number : NCT06097364

  • Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia

    NCT Number : NCT06098014

  • First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

    NCT Number : NCT06097455

  • Multiple Myeloma Prognostic Indices

    NCT Number : NCT06095752

  • Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1

    NCT Number : NCT06094894

  • Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

    NCT Number : NCT06098430

  • Delving Into Participation Trends in Renal Cell Carcinoma Studies

    NCT Number : NCT06093568

  • KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

    NCT Number : NCT06097793

  • Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

    NCT Number : NCT06093672

  • HCT With PTCy in Higher-risk MDS

    NCT Number : NCT06098313

  • CyFluATG in Lower Risk MDS

    NCT Number : NCT06098326

  • Chronic Cancer Pain Management Program

    NCT Number : NCT06101849

  • Breast Cancer Resiliency Through Exercise Program (B-REP)

    NCT Number : NCT06100263

  • A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After progrEssion on ENhertu (SATEEN)

    NCT Number : NCT06100874

  • Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)

    NCT Number : NCT06102161

  • Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy

    NCT Number : NCT06099951

  • eHealth Interventions for Breast Cancer Cognitive Impairment

    NCT Number : NCT06103318

  • Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

    NCT Number : NCT06099093

  • BCG for Therapeutic Use Phase I Clinical Trial

    NCT Number : NCT06100653

  • A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy

    NCT Number : NCT06101966

  • Organoid-based Functional Precision Therapy for Advanced Breast Cancer

    NCT Number : NCT06102824

  • Development of MRF for Characterization of Brain Tumors After Radiotherapy

    NCT Number : NCT06101069

  • Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

    NCT Number : NCT06102902

  • ASCENT Intervention for Brain Tumor Patients

    NCT Number : NCT06099743

  • Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

    NCT Number : NCT06100705

  • Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.

    NCT Number : NCT06099418

  • Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)

    NCT Number : NCT06100328

  • Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

    NCT Number : NCT06099119

  • Development of a Fluorescent Visualization System for Non-visible Lung Cancer Nodules

    NCT Number : NCT06101394

  • The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients

    NCT Number : NCT06102707

  • Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

    NCT Number : NCT06099990

  • Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES Study

    NCT Number : NCT06102876

  • An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With HER2+ Locally Advanced and/ or Metastatic Solid Tumors

    NCT Number : NCT06101082

  • Prophylactic Oral Vitamin D and Zinc for Radiation-Induced Oral Mucositis in Head and Neck Cancer

    NCT Number : NCT06100692

  • A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

    NCT Number : NCT06099782

  • Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin

    NCT Number : NCT06103279

  • The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies

    NCT Number : NCT06099925

  • KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade

    NCT Number : NCT06099821

  • Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck

    NCT Number : NCT06100081

  • Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

    NCT Number : NCT06102785

  • Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

    NCT Number : NCT06100718

  • A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

    NCT Number : NCT06099769

  • HOBBIT 3: Mental Exercises and Temporal Alteration

    NCT Number : NCT06100068

  • Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer

    NCT Number : NCT06102772

  • Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed

    NCT Number : NCT06102759

  • Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine

    NCT Number : NCT06102018

  • Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy

    NCT Number : NCT06104371

  • Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis

    NCT Number : NCT06104618

  • Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting Induced by Radiochemotherapy in Head and Neck Squamous Cell Carcinoma

    NCT Number : NCT06102447

  • 99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer

    NCT Number : NCT06104085

  • Qualitative Techniques to Define Meaningful Within-Patient Change in Symptoms of Advanced Cancer Patients

    NCT Number : NCT06104657

  • Medical Tai Chi Exercise Healing in Treating mCRC Patients

    NCT Number : NCT06104267

  • The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery

    NCT Number : NCT06104774

  • PECS II Block and Single Port Robot-assisted Transaxillary Thyroidectomy

    NCT Number : NCT06101043

  • A Study of Avutometinib for People With Solid Tumor Cancers

    NCT Number : NCT06104488

  • Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD

    NCT Number : NCT06092281

  • LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)

    NCT Number : NCT06103682

  • Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

    NCT Number : NCT06103669

  • Tumor Vaccines for Solid Tumors

    NCT Number : NCT06102837

  • Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

    NCT Number : NCT06101277

  • 11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

    NCT Number : NCT06100367

  • A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

    NCT Number : NCT06100003

  • A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

    NCT Number : NCT06100016

  • A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation

    NCT Number : NCT06102928

  • Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

    NCT Number : NCT06101290

  • Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as an Adjuvant Treatment in Endometrial Carcinoma

    NCT Number : NCT06102252

  • Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice

    NCT Number : NCT06103916

  • BGT007 Cells for the Treatment of Refractory Digestive System Tumors

    NCT Number : NCT06104241

  • BGT007H Cells for the Treatment of Refractory Digestive System Tumors

    NCT Number : NCT06104215

  • Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC

    NCT Number : NCT06100497

  • Teclistamab or Talquetamab in Combination With Daratumumab for High-Risk Smoldering Myeloma (REVIVE Study)

    NCT Number : NCT06100237

  • Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma

    NCT Number : NCT06102746

  • Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

    NCT Number : NCT06104592

  • A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

    NCT Number : NCT06102525

  • Immunonutrition in ERAS Protocols in Gynecologic Oncology

    NCT Number : NCT06103526

  • Optimization of Fractionation Schedules of Heel Spur Radiotherapy Prospective Randomized Open-label Trial

    NCT Number : NCT06104410

  • Binaural Sound for Remimazolam Induction

    NCT Number : NCT06099977

  • A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone

    NCT Number : NCT06104878

  • Fruquintinib in the Cross-line Treatment of Refractory mCRC

    NCT Number : NCT06099314

  • Plasma Extracellular Vesicles in Meningioma Patients

    NCT Number : NCT06104930

  • PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

    NCT Number : NCT06102057

  • A Study of [14C]-LOXO-783 in Healthy Adult Participants

    NCT Number : NCT06102512

  • Siderophore-labelled Position Emission Tomography for Correlating Invasive Fungal InfeCtions

    NCT Number : NCT06105411

  • EEG Characteristics and Postoperative Delirium

    NCT Number : NCT06102967

  • Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation

    NCT Number : NCT06102213

  • A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma

    NCT Number : NCT06104553

  • Feasibility of Using Surplus qFIT Samples to Investigate the Gut Microbiota.

    NCT Number : NCT06100549

  • A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis

    NCT Number : NCT06104683

  • Genetic Susceptibility to Severe Infections

    NCT Number : NCT06102070

  • PFA 100 Evaluation and Reference Interval HOACNY

    NCT Number : NCT06100510

  • Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

    NCT Number : NCT06103890

  • Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography

    NCT Number : NCT06099275

  • Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI

    NCT Number : NCT06100796

  • Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC

    NCT Number : NCT06102395

  • A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

    NCT Number : NCT06100744

  • Dynamic Frailty Assessment for Guiding the Treatment in Older Adults With Newly Diagnosed Multiple Myeloma

    NCT Number : NCT06099912

  • Cohort Study in Fujian Province

    NCT Number : NCT06102187

  • Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction

    NCT Number : NCT06101719

  • A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

    NCT Number : NCT06101134

  • Feasibility of the AveCure Microwave Ablation Technology for the Bronchoscopic Treatment of Malignant Central Airway Obstructions

    NCT Number : NCT06105606

  • Immunology of Ebola Vaccine

    NCT Number : NCT06100913

  • Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

    NCT Number : NCT06105658

  • A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene.

    NCT Number : NCT06105619

  • Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

    NCT Number : NCT06102863

  • SIBTime Phase II: Web Application for Typically Developing Siblings

    NCT Number : NCT06099457

  • Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis

    NCT Number : NCT06101823

  • Driving Pressure During General Anesthesia for Minimally Invasive Abdominal Surgery (GENERATOR)

    NCT Number : NCT06101511

  • Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

    NCT Number : NCT06099366

  • Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma

    NCT Number : NCT06104709

  • Pilot Study on Trametinib for Surgical Unruptured AVMs

    NCT Number : NCT06098872

  • CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

    NCT Number : NCT06101381

  • Ovary Syndrome for Efficient Diagnosis and Targeted Therapy

    NCT Number : NCT06102629

  • Prevalence of ENT Diseseas

    NCT Number : NCT06105346

  • Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial

    NCT Number : NCT06101147

  • A Exploratory Trial of WTX212A Injection in the Treatment of Patients With Advanced Lung Cancer

    NCT Number : NCT06106152

  • Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study

    NCT Number : NCT06105177

  • The Effect of Dignity Therapy Applied to Cancer Patients

    NCT Number : NCT06105359

  • TIL Therapy for Patients With Advanced Solid Tumors

    NCT Number : NCT06107894

  • Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer

    NCT Number : NCT06105008

  • Improving Muslim Women's Uptake of Cancer Screening (IMCAN)

    NCT Number : NCT06106165

  • Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer

    NCT Number : NCT06105515

  • Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

    NCT Number : NCT06108232

  • A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

    NCT Number : NCT06105632

  • Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

    NCT Number : NCT06108089

  • A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

    NCT Number : NCT06106360

  • Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

    NCT Number : NCT06103617

  • An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions

    NCT Number : NCT06106568

  • Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab

    NCT Number : NCT06107413

  • Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

    NCT Number : NCT06105684

  • Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer

    NCT Number : NCT06107868

  • Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

    NCT Number : NCT06106308

  • Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

    NCT Number : NCT06106477

  • Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy

    NCT Number : NCT06107920

  • RATME vs LATME in Middle and Low Rectal Cancer

    NCT Number : NCT06105203

  • The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).

    NCT Number : NCT06106711

  • A Study of MK-5684 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)

    NCT Number : NCT06104449

  • Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

    NCT Number : NCT06107374

  • JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

    NCT Number : NCT06108050

  • TBNA vs EBUS-TBNA Plus Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing

    NCT Number : NCT06105801

  • A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

    NCT Number : NCT06103864

  • Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

    NCT Number : NCT06105918

  • A Study of YL202 in Selected Patients With Advanced Solid Tumors

    NCT Number : NCT06107686

  • Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

    NCT Number : NCT06105021

  • REDucing Hot FLASHes in Women Using Endocrine Therapy.

    NCT Number : NCT06106529

  • Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma

    NCT Number : NCT06105554

  • Ketogenic Diet Improves Thrombocytopenia in Cancer Patients

    NCT Number : NCT06106139

  • Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"

    NCT Number : NCT06107478

  • Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma

    NCT Number : NCT06107738

  • 18F-Fluciclovine PET/CT in Multiple Myeloma

    NCT Number : NCT06103838

  • Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment

    NCT Number : NCT06106802

  • CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    NCT Number : NCT06106776

  • Biennial CEM in Women With a Personal History of Breast Cancer

    NCT Number : NCT06105749

  • Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer (EBC)

    NCT Number : NCT06107673

  • Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

    NCT Number : NCT06106282

  • Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors

    NCT Number : NCT06107608

  • Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow

    NCT Number : NCT06106997

  • Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell Carcinoma

    NCT Number : NCT06107114

  • A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease (SatraGO-2)

    NCT Number : NCT06106828

Want alerts of new clinical trials into your email inbox? Subscribe today

Find a Trial

Enter a few details below to get started and we'll help you match up with active clinical trials

Cancer Details

9200 Trials found

Cancer Details

Eligibility Criteria


OncoPower Clinical Trial Features

OncoPower Clinical Trial Features


Clinical Trial Matching

Fill out your profile and we’ll match you with clinical trial opportunities that are tailored to you


Eligiblity Verification

We work directly with the researchers on your behalf to cut through the pile of paperwork and streamline inclusion and exclusion criteria


Reimbursement Options

Our team will connect you with financial resources available to clinical trial participants


Trial Sponsor Coordination

OncoPower works with the sponsoring organization to make sure you don’t have to do things twice when being onboarded with a clinical trial

FAQs For Patients

Clinical trials for cancer often compare a new drug or treatment modality with the current standard of care. Depending on the trial, you may be able to stay on your current medication. In addition to that, some Clinical trials in cancer are observational and follow a large population over several years and try to understand how other factors impact disease progression and survivorship. These often allow you to continue your course of treatment with your current team and answer survey questions from the research team.

There are some clinical trials that provide compensation and/or reimbursement for expenses. One advantage of using OncoPower to identify and connect with the right clinical trial is that we do some of this legwork for you. Our team will help identify and connect you with financial benefits open to you (some through the study sponsor, some through outside non-profits).

Time spent will vary greatly depending on the clinical trial and treatment being studied. OncoPower will help you understand this as you will find this information out during the informed consent process.

You are able to leave a clinical trial at any time, for any reason.

Every clinical trial has unique and specific inclusion and exclusion criteria that help the researchers. If you don’t qualify for a trial you’re interested in but would like to learn about more trials, simply fill out your patient profile on OncoPower and indicate that you’re interested in Clinical Trials and we’ll help match you to suitable trials.

Create Your Free Account Today

Begin offering a comprehensive digital experience for your patients.